Loading...
XSHE000411
Market cap698mUSD
Jan 10, Last price  
9.88CNY
1D
-2.37%
1Q
-1.40%
Name

Zhejiang Int'l Group Co.

Chart & Performance

D1W1MN
XSHE:000411 chart
P/E
10.47
P/S
0.16
EPS
0.94
Div Yield, %
4.08%
Shrs. gr., 5y
13.65%
Rev. gr., 5y
9.36%
Revenues
32.05b
+4.68%
2,083,776,7372,475,327,7982,742,138,0893,382,360,8324,098,883,0695,077,116,1566,638,251,3368,526,353,58310,589,954,54412,369,304,35114,073,811,13515,466,436,91617,257,326,55018,907,331,04020,492,140,93724,600,927,15625,008,204,65326,730,979,47030,619,257,33132,052,121,585
Net income
489m
+5.67%
481,6765,830,9096,796,11414,511,27019,038,88231,408,29042,402,087187,272,54467,680,71774,090,25965,447,13768,758,64686,847,59983,490,54493,851,378337,672,269342,810,991396,133,198462,528,161488,732,096
CFO
425m
+8.73%
072,625,84667,697,2820122,159,72442,950,61391,138,847069,437,20375,720,99688,049,36394,336,215141,528,430158,458,167166,314,176220,561,595332,241,463326,023,869391,167,270425,313,727
Dividend
May 29, 20240.3045 CNY/sh
Earnings
May 14, 2025

Profile

Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. The company was founded in 1950 and is based in Hangzhou, China.
URL
http://www.intmedic.com
IPO date
Jul 16, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
32,052,122
4.68%
30,619,257
14.55%
Cost of revenue
30,425,409
29,406,018
Unusual Expense (Income)
NOPBT
1,626,713
1,213,239
NOPBT Margin
5.08%
3.96%
Operating Taxes
212,657
163,685
Tax Rate
13.07%
13.49%
NOPAT
1,414,056
1,049,554
Net income
488,732
5.67%
462,528
16.76%
Dividends
(209,015)
(51,075)
Dividend yield
3.93%
1.35%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,871,320
1,431,387
Long-term debt
821,941
583,216
Deferred revenue
79,207
85,762
Other long-term liabilities
23
Net debt
1,040,876
929,161
Cash flow
Cash from operating activities
425,314
391,167
CAPEX
(168,363)
Cash from investing activities
(64,971)
Cash from financing activities
363,931
FCF
622,548
452,330
Balance
Cash
1,607,074
864,882
Long term investments
45,311
220,560
Excess cash
49,780
Stockholders' equity
2,695,313
3,482,341
Invested Capital
7,353,615
5,803,388
ROIC
21.50%
18.78%
ROCE
21.87%
20.81%
EV
Common stock shares outstanding
474,497
326,506
Price
11.21
-3.11%
11.57
-5.29%
Market cap
5,319,113
40.80%
3,777,676
-3.26%
EV
6,887,725
6,506,132
EBITDA
1,790,420
1,359,560
EV/EBITDA
3.85
4.79
Interest
162,407
160,582
Interest/NOPBT
9.98%
13.24%